Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DISHMAN PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
TEVA PHARMA
Dec-13
DISHMAN PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3743,479-   
Low Rs1293,022-   
Sales per share (Unadj.) Rs197.01,996.4-  
Earnings per share (Unadj.) Rs21.2124.7-  
Cash flow per share (Unadj.) Rs34.7286.1-  
Dividends per share (Unadj.) Rs2.00109.18-  
Avg Dividend yield %0.83.4 23.7%  
Book value per share (Unadj.) Rs179.92,217.6-  
Shares outstanding (eoy) m80.70848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.6 78.5%   
Avg P/E ratio x11.926.1 45.6%  
P/CF ratio (eoy) x7.311.4 63.8%  
Price / Book Value ratio x1.41.5 95.5%  
Dividend payout %9.487.5 10.8%   
Avg Mkt Cap Rs m20,3072,756,220 0.7%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m5,3550-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m15,8981,692,969 0.9%  
Other income Rs m2650-   
Total revenues Rs m16,1631,692,969 1.0%   
Gross profit Rs m4,103463,620 0.9%  
Depreciation Rs m1,091136,844 0.8%   
Interest Rs m94433,253 2.8%   
Profit before tax Rs m2,334293,523 0.8%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m624-3,584 -17.4%   
Profit after tax Rs m1,710105,758 1.6%  
Gross profit margin %25.827.4 94.2%  
Effective tax rate %26.7-1.2 -2,188.8%   
Net profit margin %10.86.2 172.2%  
BALANCE SHEET DATA
Current assets Rs m11,0181,143,425 1.0%   
Current liabilities Rs m9,517997,163 1.0%   
Net working cap to sales %9.48.6 109.3%  
Current ratio x1.21.1 101.0%  
Inventory Days Days5791 62.8%  
Debtors Days Days396 3.6%  
Net fixed assets Rs m18,787552,961 3.4%   
Share capital Rs m1614,167 3.9%   
"Free" reserves Rs m14,3540-   
Net worth Rs m14,5161,880,567 0.8%   
Long term debt Rs m4,189865,653 0.5%   
Total assets Rs m29,8053,868,976 0.8%  
Interest coverage x3.59.8 35.3%   
Debt to equity ratio x0.30.5 62.7%  
Sales to assets ratio x0.50.4 121.9%   
Return on assets %8.93.6 247.9%  
Return on equity %11.85.6 209.5%  
Return on capital %17.54.9 355.4%  
Exports to sales %24.90-   
Imports to sales %3.70-   
Net fx Rs m4,2550-   
CASH FLOW
From Operations Rs m2,786269,772 1.0%  
From Investments Rs m-1,529-95,591 1.6%  
From Financial Activity Rs m-941-323,609 0.3%  
Net Cashflow Rs m317-149,429 -0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare DISHMAN PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare DISHMAN PHARMA With: NATURAL CAPS  HESTER BIOSCIENCES  CIPLA  KOPRAN.  PARENT.DRUGS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.